| Identification | Back Directory | [Name]
21-[4-(4-Amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-4,7,10,13,16,19-hexaoxaheneicosanoic acid | [CAS]
2388520-23-6 | [Synonyms]
TLR7/8 agonist 4 hydroxy-PEG6-acid
21-[4-(4-Amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-4,7,10,13,16,19-hexaoxaheneicosanoic acid | [Molecular Formula]
C33H52N6O8 | [MOL File]
2388520-23-6.mol | [Molecular Weight]
660.8 |
| Chemical Properties | Back Directory | [Boiling point ]
858.7±65.0 °C(Predicted) | [density ]
1.226±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | [pka]
4.28±0.10(Predicted) |
| Hazard Information | Back Directory | [Uses]
TLR7/8 agonist 4 hydroxy-PEG6-acid is a drug-linker conjugates for ADC. TLR7/8 agonist 4 hydroxy-PEG6-acid consists of TLR7/8 agonist 4 (HY-139017) and a non-cleavable linker Hydroxy-PEG6-acid (HY-133050), and can be used for synthesis of ADCs[1]. | [References]
[1] Shelley Erin ACKERMAN, et al. Macromolecule-supported tlr agonists. Patent. WO2020190762A1. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|